Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Omics
"life science and biotechnology researchers have begun to use âomicsâ technologies to analyze the molecular profile 1 of individual cells. Techniques of genomics, transcriptomics, proteomics, or lipidomics have been utilized in studies of a variety of organisms, including C. albicans for gaining a systematic understanding of physiological phenomena combined with molecular profiles. Concerning a search for vilurence-related proteins from C. lbicans y using omics technology, proteomics is superior to other technologies because direct analysis of protein is going to be performed. Here, we first review studies that have used a proteomic approach to analyze proteins of C. albicans with liquid chromatography and tandem mass spectrometry (LC-MS/MS) equipped with long monolithic silica capillary columns.
OMICS Group International is one of the leading Open Access Publishers which is publishing 700+ peer-reviewed journals with the support of 50,000+ editorial board members as editorial team and aimed to disseminate the scholarly knowledge to the scientific society. OMICS Group also organizing 3000+ International Scientific Conferences and events yearly all over the world with the support of 1000+ Scientific associations worldwide.
Citation: Shibasaki S, Karasaki M, Ueda M (2014) Combining Proteomic Strategies and Molecular Display Technology for Development of Vaccines against Candida albicans. J Proteomics Bioinform 7: 134-138."
- Share this page
Last date updated on January, 2021